Side effects of GLP-1 shots: what to expect. - Reddit

Why do GLP-1 shots cause side effects?

GLP-1 receptor agonists (like semaglutide and tirzepatide) work partly by slowing gastric emptying — the rate at which food moves from the stomach into the small intestine. That mechanism is a central reason they help with weight management, but it’s also why GI side effects are so common early in treatment. The stomach is holding food longer, and the brain’s appetite signaling is being reset.

Most protocols use a slow titration — starting at the lowest dose and increasing by small increments over weeks to months — because this approach consistently reduces the side-effect burden compared to jumping straight to therapeutic doses.

What are the most common side effects of GLP-1 shots?

Nausea (40–50% of patients)

Nausea is the defining early side effect of GLP-1 therapy. In the large clinical trials for semaglutide and tirzepatide, roughly 40–50% of patients reported nausea at some point — but the majority characterized it as mild to moderate, and most saw significant improvement within the first few weeks of each dose level. A handful of practical strategies help:

• Eat smaller meals; avoid high-fat or high-sugar foods on injection day.
• Stay hydrated throughout the day.
• Avoid eating large meals right before or after the injection.
• Some patients find evening injections reduce daytime nausea awareness.

If nausea is severe or persistent beyond two weeks at a given dose, contact your clinician — a dose hold or slower titration is an option, not a failure.

Vomiting (15–25% of patients)

Vomiting rates are lower than nausea but still clinically significant. Like nausea, it tends to occur in the early weeks of a new dose. Persistent vomiting that limits hydration or eating is a reason to contact your clinician promptly — it can cause dehydration and electrolyte imbalance if unchecked.

Constipation (10–20% of patients)

Slowed GI motility can cause constipation, particularly in patients who are eating significantly less than they were before starting therapy. Increasing fiber intake, maintaining hydration, and staying physically active help most patients manage this well.

Diarrhea (10–15% of patients)

Less common than constipation but also reported. Often transient and linked to specific meals rather than to the medication itself. If it’s persistent, a dietary review and clinician check-in are appropriate.

Injection-site reactions

Redness, mild bruising, itching, or a small lump at the injection site are common with any subcutaneous injection. Rotating injection sites (abdomen, outer thigh, back of upper arm) across each week helps. Severe pain, warmth, or spreading redness at a site should be evaluated.

Fatigue and reduced appetite

Many patients experience fatigue early in treatment, often compounded by eating less. This generally improves as the body adjusts. Ensuring adequate protein intake helps preserve lean mass during the weight management phase.

Less common but important side effects

Gallbladder events

Rapid weight loss of any cause can increase gallstone formation risk. GLP-1 therapy trials have shown a small but real increase in gallbladder-related events (gallstones, cholecystitis) compared to placebo. If you experience upper-right abdominal pain, especially after meals, report it to your clinician. Pre-existing gallbladder disease is a relevant history item.

Pancreatitis (rare)

Acute pancreatitis has been reported with GLP-1 class medications. The absolute risk is low, but it is a serious adverse event. Classic symptoms include persistent severe pain in the upper abdomen, often radiating to the back, accompanied by nausea and vomiting. This is a medical emergency — do not wait it out. GLP-1 therapy is generally contraindicated in patients with a history of pancreatitis.

Hypoglycemia (in combination with other medications)

GLP-1 receptor agonists used in the context of weight management in non-diabetic patients carry a low standalone risk of hypoglycemia. The risk increases if combined with insulin or sulfonylureas. Your prescribing clinician will account for your medication list.

Heart rate increase

Some patients experience a modest resting heart rate increase (typically 2–4 bpm). For most people this is clinically insignificant, but patients with underlying cardiac conditions should mention it to their clinician.

Which GLP-1 side effects require calling your clinician immediately?

• Severe, persistent mid-abdominal pain — especially radiating to the back. Rule out pancreatitis.
• Upper-right abdominal pain after meals — could indicate a gallbladder event.
• Inability to keep fluids down — vomiting severe enough to risk dehydration.
• Signs of an allergic reaction — hives, facial swelling, difficulty breathing after injection.
• Rapid or irregular heartbeat that is new, sustained, or accompanied by chest discomfort.
• Signs of low blood sugar (if on other glucose-lowering medications) — shakiness, sweating, confusion.

A note on compounded formulations

Compounded semaglutide and tirzepatide are not FDA-approved drugs. The side effect profile of the active molecule is expected to be the same as branded versions, but product quality — purity, sterility, accurate dosing — depends entirely on the compounding pharmacy’s standards. PepScribe works only with licensed 503A compounding pharmacies based in the USA. No hidden overseas supply chain. Clinician oversight, a proper intake evaluation, and ongoing check-ins are the standard of care, not optional extras.

Managing side effects: the titration principle

The single most effective way to reduce the side effects of GLP-1 shots is slow, systematic dose titration. Starting low and increasing gradually over months — not weeks — gives the GI tract time to adapt. Trying to rush to the therapeutic dose to see results faster almost always results in worse side effects and higher discontinuation rates.

Clinicians also individualize titration based on how you’re tolerating each dose level. A longer hold at a low dose before increasing is a normal and reasonable adjustment, not a sign that the medication isn’t working.

Frequently asked questions